This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Petravic, J.
Right arrow Articles by Davenport, M. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Petravic, J.
Right arrow Articles by Davenport, M. P.

 Previous Article  |  Next Article 

Journal of Virology, April 2008, p. 4091-4101, Vol. 82, No. 8
0022-538X/08/$08.00+0     doi:10.1128/JVI.02552-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

CD4+ Target Cell Availability Determines the Dynamics of Immune Escape and Reversion In Vivo{triangledown}

Janka Petravic,1 Liyen Loh,2 Stephen J. Kent,2 and Miles P. Davenport1*

Complex Systems in Biology Group, Centre for Vascular Research, University of NSW, Kensington, NSW 2052, Australia,1 Department of Microbiology and Immunology, University of Melbourne, Melbourne 3010, Australia2

Received 29 November 2007/ Accepted 30 January 2008

Infections with human immunodeficiency virus (HIV) and the closely related monkey viruses simian-human immunodeficiency virus (SHIV) and simian immunodeficiency virus (SIV) are characterized by progressive waves of immune responses, followed by viral mutation and "immune escape." However, escape mutation usually leads to lower replicative fitness, and in the absence of immune pressure, an escape mutant (EM) virus "reverts" to the wild-type phenotype. Analysis of the dynamics of immune escape and reversion has suggested it is a mechanism for identifying the immunogens best capable of controlling viremia. We have analyzed and modeled data of the dynamics of wild-type (WT) and EM viruses during SHIV infection of macaques. Modeling suggests that the dynamics of reversion and immune escape should be determined by the availability of target cells for infection. Consistent with this suggestion, we find that the rate of reversion of cytotoxic T-lymphocyte (CTL) EM virus strongly correlates with the number of CD4+ T cells available for infection. This phenomenon also affects the rate of immune escape, since this rate is determined by the balance of CTL killing and the WT fitness advantage. This analysis predicts that the optimal timing for the selection of immune escape variants will be immediately after the peak of viremia and that the development of escape variants at later times will lead to slower selection. This has important implications for comparative studies of immune escape and reversion in different infections and for identifying epitopes with high fitness cost for use as vaccine targets.

* Corresponding author. Mailing address: Complex Systems in Biology Group, Centre for Vascular Research, University of New South Wales, Kensington, NSW 2052, Australia. Phone: 61 2 93852762. Fax: 61 2 93851389. E-mail: m.davenport{at}unsw.edu.au

{triangledown} Published ahead of print on 13 February 2008.

Journal of Virology, April 2008, p. 4091-4101, Vol. 82, No. 8
0022-538X/08/$08.00+0     doi:10.1128/JVI.02552-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Goonetilleke, N., Liu, M. K.P., Salazar-Gonzalez, J. F., Ferrari, G., Giorgi, E., Ganusov, V. V., Keele, B. F., Learn, G. H., Turnbull, E. L., Salazar, M. G., Weinhold, K. J., Moore, S., CHAVI Clinical Core B, , Letvin, N., Haynes, B. F., Cohen, M. S., Hraber, P., Bhattacharya, T., Borrow, P., Perelson, A. S., Hahn, B. H., Shaw, G. M., Korber, B. T., McMichael, A. J. (2009). The first T cell response to transmitted/founder virus contributes to the control of acute viremia in HIV-1 infection. JEM 206: 1253-1272 [Abstract] [Full Text]  
  • Soriano, V., Perelson, A. S., Zoulim, F. (2008). Why are there different dynamics in the selection of drug resistance in HIV and hepatitis B and C viruses?. J Antimicrob Chemother 62: 1-4 [Abstract] [Full Text]  


Copyright © 2010 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»